Non-oncology Biopharmaceuticals Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biologics
        1.2.3 Biosimilars
    1.3 Market by Application
        1.3.1 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Immunology
        1.3.3 Endocrinology
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Non-oncology Biopharmaceuticals Market Perspective (2017-2028)
    2.2 Non-oncology Biopharmaceuticals Growth Trends by Region
        2.2.1 Non-oncology Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Non-oncology Biopharmaceuticals Historic Market Size by Region (2017-2022)
        2.2.3 Non-oncology Biopharmaceuticals Forecasted Market Size by Region (2023-2028)
    2.3 Non-oncology Biopharmaceuticals Market Dynamics
        2.3.1 Non-oncology Biopharmaceuticals Industry Trends
        2.3.2 Non-oncology Biopharmaceuticals Market Drivers
        2.3.3 Non-oncology Biopharmaceuticals Market Challenges
        2.3.4 Non-oncology Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non-oncology Biopharmaceuticals Players by Revenue
        3.1.1 Global Top Non-oncology Biopharmaceuticals Players by Revenue (2017-2022)
        3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Players (2017-2022)
    3.2 Global Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non-oncology Biopharmaceuticals Revenue
    3.4 Global Non-oncology Biopharmaceuticals Market Concentration Ratio
        3.4.1 Global Non-oncology Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non-oncology Biopharmaceuticals Revenue in 2021
    3.5 Non-oncology Biopharmaceuticals Key Players Head office and Area Served
    3.6 Key Players Non-oncology Biopharmaceuticals Product Solution and Service
    3.7 Date of Enter into Non-oncology Biopharmaceuticals Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non-oncology Biopharmaceuticals Breakdown Data by Type
    4.1 Global Non-oncology Biopharmaceuticals Historic Market Size by Type (2017-2022)
    4.2 Global Non-oncology Biopharmaceuticals Forecasted Market Size by Type (2023-2028)
5 Non-oncology Biopharmaceuticals Breakdown Data by Application
    5.1 Global Non-oncology Biopharmaceuticals Historic Market Size by Application (2017-2022)
    5.2 Global Non-oncology Biopharmaceuticals Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Non-oncology Biopharmaceuticals Market Size (2017-2028)
    6.2 North America Non-oncology Biopharmaceuticals Market Size by Type
        6.2.1 North America Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
        6.2.2 North America Non-oncology Biopharmaceuticals Market Size by Type (2023-2028)
        6.2.3 North America Non-oncology Biopharmaceuticals Market Share by Type (2017-2028)
    6.3 North America Non-oncology Biopharmaceuticals Market Size by Application
        6.3.1 North America Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
        6.3.2 North America Non-oncology Biopharmaceuticals Market Size by Application (2023-2028)
        6.3.3 North America Non-oncology Biopharmaceuticals Market Share by Application (2017-2028)
    6.4 North America Non-oncology Biopharmaceuticals Market Size by Country
        6.4.1 North America Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
        6.4.2 North America Non-oncology Biopharmaceuticals Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Non-oncology Biopharmaceuticals Market Size (2017-2028)
    7.2 Europe Non-oncology Biopharmaceuticals Market Size by Type
        7.2.1 Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
        7.2.2 Europe Non-oncology Biopharmaceuticals Market Size by Type (2023-2028)
        7.2.3 Europe Non-oncology Biopharmaceuticals Market Share by Type (2017-2028)
    7.3 Europe Non-oncology Biopharmaceuticals Market Size by Application
        7.3.1 Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
        7.3.2 Europe Non-oncology Biopharmaceuticals Market Size by Application (2023-2028)
        7.3.3 Europe Non-oncology Biopharmaceuticals Market Share by Application (2017-2028)
    7.4 Europe Non-oncology Biopharmaceuticals Market Size by Country
        7.4.1 Europe Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
        7.4.2 Europe Non-oncology Biopharmaceuticals Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non-oncology Biopharmaceuticals Market Size (2017-2028)
    8.2 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Type
        8.2.1 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Share by Type (2017-2028)
    8.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Application
        8.3.1 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Share by Application (2017-2028)
    8.4 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region
        8.4.1 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Non-oncology Biopharmaceuticals Market Size (2017-2028)
    9.2 Latin America Non-oncology Biopharmaceuticals Market Size by Type
        9.2.1 Latin America Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
        9.2.2 Latin America Non-oncology Biopharmaceuticals Market Size by Type (2023-2028)
        9.2.3 Latin America Non-oncology Biopharmaceuticals Market Share by Type (2017-2028)
    9.3 Latin America Non-oncology Biopharmaceuticals Market Size by Application
        9.3.1 Latin America Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
        9.3.2 Latin America Non-oncology Biopharmaceuticals Market Size by Application (2023-2028)
        9.3.3 Latin America Non-oncology Biopharmaceuticals Market Share by Application (2017-2028)
    9.4 Latin America Non-oncology Biopharmaceuticals Market Size by Country
        9.4.1 Latin America Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
        9.4.2 Latin America Non-oncology Biopharmaceuticals Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non-oncology Biopharmaceuticals Market Size (2017-2028)
    10.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type
        10.2.1 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Share by Type (2017-2028)
    10.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application
        10.3.1 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Share by Application (2017-2028)
    10.4 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country
        10.4.1 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Non-oncology Biopharmaceuticals Introduction
        11.1.4 Roche Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Non-oncology Biopharmaceuticals Introduction
        11.2.4 Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Introduction
        11.3.4 Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Non-oncology Biopharmaceuticals Introduction
        11.4.4 Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.4.5 Pfizer Recent Developments
    11.5 Novo Nordisk
        11.5.1 Novo Nordisk Company Details
        11.5.2 Novo Nordisk Business Overview
        11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Introduction
        11.5.4 Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.5.5 Novo Nordisk Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Non-oncology Biopharmaceuticals Introduction
        11.6.4 Novartis Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Non-oncology Biopharmaceuticals Introduction
        11.7.4 Merck Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.7.5 Merck Recent Developments
    11.8 Teva
        11.8.1 Teva Company Details
        11.8.2 Teva Business Overview
        11.8.3 Teva Non-oncology Biopharmaceuticals Introduction
        11.8.4 Teva Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.8.5 Teva Recent Developments
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Details
        11.9.2 Eli Lilly Business Overview
        11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Introduction
        11.9.4 Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.9.5 Eli Lilly Recent Developments
    11.10 Bristol-Myers Squibb
        11.10.1 Bristol-Myers Squibb Company Details
        11.10.2 Bristol-Myers Squibb Business Overview
        11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Introduction
        11.10.4 Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.10.5 Bristol-Myers Squibb Recent Developments
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Details
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Introduction
        11.11.4 GlaxoSmithKline Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.11.5 GlaxoSmithKline Recent Developments
    11.12 UCB Pharma
        11.12.1 UCB Pharma Company Details
        11.12.2 UCB Pharma Business Overview
        11.12.3 UCB Pharma Non-oncology Biopharmaceuticals Introduction
        11.12.4 UCB Pharma Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.12.5 UCB Pharma Recent Developments
    11.13 Amgen
        11.13.1 Amgen Company Details
        11.13.2 Amgen Business Overview
        11.13.3 Amgen Non-oncology Biopharmaceuticals Introduction
        11.13.4 Amgen Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.13.5 Amgen Recent Developments
    11.14 AbbVie
        11.14.1 AbbVie Company Details
        11.14.2 AbbVie Business Overview
        11.14.3 AbbVie Non-oncology Biopharmaceuticals Introduction
        11.14.4 AbbVie Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.14.5 AbbVie Recent Developments
    11.15 Takeda
        11.15.1 Takeda Company Details
        11.15.2 Takeda Business Overview
        11.15.3 Takeda Non-oncology Biopharmaceuticals Introduction
        11.15.4 Takeda Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.15.5 Takeda Recent Developments
    11.16 AstraZeneca
        11.16.1 AstraZeneca Company Details
        11.16.2 AstraZeneca Business Overview
        11.16.3 AstraZeneca Non-oncology Biopharmaceuticals Introduction
        11.16.4 AstraZeneca Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.16.5 AstraZeneca Recent Developments
    11.17 Mylan
        11.17.1 Mylan Company Details
        11.17.2 Mylan Business Overview
        11.17.3 Mylan Non-oncology Biopharmaceuticals Introduction
        11.17.4 Mylan Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.17.5 Mylan Recent Developments
    11.18 LEO Pharma
        11.18.1 LEO Pharma Company Details
        11.18.2 LEO Pharma Business Overview
        11.18.3 LEO Pharma Non-oncology Biopharmaceuticals Introduction
        11.18.4 LEO Pharma Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.18.5 LEO Pharma Recent Developments
    11.19 Boehringer Ingelheim
        11.19.1 Boehringer Ingelheim Company Details
        11.19.2 Boehringer Ingelheim Business Overview
        11.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Introduction
        11.19.4 Boehringer Ingelheim Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.19.5 Boehringer Ingelheim Recent Developments
    11.20 Alexion Pharmaceuticals
        11.20.1 Alexion Pharmaceuticals Company Details
        11.20.2 Alexion Pharmaceuticals Business Overview
        11.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Introduction
        11.20.4 Alexion Pharmaceuticals Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.20.5 Alexion Pharmaceuticals Recent Developments
    11.21 Elusys Therapeutics
        11.21.1 Elusys Therapeutics Company Details
        11.21.2 Elusys Therapeutics Business Overview
        11.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Introduction
        11.21.4 Elusys Therapeutics Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.21.5 Elusys Therapeutics Recent Developments
    11.22 Swedish Orphan Biovitrum
        11.22.1 Swedish Orphan Biovitrum Company Details
        11.22.2 Swedish Orphan Biovitrum Business Overview
        11.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Introduction
        11.22.4 Swedish Orphan Biovitrum Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.22.5 Swedish Orphan Biovitrum Recent Developments
    11.23 Biogen
        11.23.1 Biogen Company Details
        11.23.2 Biogen Business Overview
        11.23.3 Biogen Non-oncology Biopharmaceuticals Introduction
        11.23.4 Biogen Revenue in Non-oncology Biopharmaceuticals Business (2017-2022)
        11.23.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Biosimilars
    Table 4. Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Non-oncology Biopharmaceuticals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Non-oncology Biopharmaceuticals Market Share by Region (2017-2022)
    Table 8. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Non-oncology Biopharmaceuticals Market Share by Region (2023-2028)
    Table 10. Non-oncology Biopharmaceuticals Market Trends
    Table 11. Non-oncology Biopharmaceuticals Market Drivers
    Table 12. Non-oncology Biopharmaceuticals Market Challenges
    Table 13. Non-oncology Biopharmaceuticals Market Restraints
    Table 14. Global Non-oncology Biopharmaceuticals Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Non-oncology Biopharmaceuticals Revenue Share by Players (2017-2022)
    Table 16. Global Top Non-oncology Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2021)
    Table 17. Ranking of Global Top Non-oncology Biopharmaceuticals Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Non-oncology Biopharmaceuticals Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Non-oncology Biopharmaceuticals Product Solution and Service
    Table 21. Date of Enter into Non-oncology Biopharmaceuticals Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Non-oncology Biopharmaceuticals Revenue Market Share by Type (2017-2022)
    Table 25. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Non-oncology Biopharmaceuticals Revenue Market Share by Type (2023-2028)
    Table 27. Global Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Non-oncology Biopharmaceuticals Revenue Share by Application (2017-2022)
    Table 29. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Non-oncology Biopharmaceuticals Revenue Share by Application (2023-2028)
    Table 31. North America Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Non-oncology Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Non-oncology Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Non-oncology Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Non-oncology Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Non-oncology Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Non-oncology Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Non-oncology Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Non-oncology Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Non-oncology Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Non-oncology Biopharmaceuticals Product
    Table 64. Roche Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Developments
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Non-oncology Biopharmaceuticals Product
    Table 69. Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 70. Sanofi Recent Developments
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Non-oncology Biopharmaceuticals Product
    Table 74. Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 75. Johnson & Johnson Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Non-oncology Biopharmaceuticals Product
    Table 79. Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Novo Nordisk Company Details
    Table 82. Novo Nordisk Business Overview
    Table 83. Novo Nordisk Non-oncology Biopharmaceuticals Product
    Table 84. Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 85. Novo Nordisk Recent Developments
    Table 86. Novartis Company Details
    Table 87. Novartis Business Overview
    Table 88. Novartis Non-oncology Biopharmaceuticals Product
    Table 89. Novartis Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 90. Novartis Recent Developments
    Table 91. Merck Company Details
    Table 92. Merck Business Overview
    Table 93. Merck Non-oncology Biopharmaceuticals Product
    Table 94. Merck Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 95. Merck Recent Developments
    Table 96. Teva Company Details
    Table 97. Teva Business Overview
    Table 98. Teva Non-oncology Biopharmaceuticals Product
    Table 99. Teva Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 100. Teva Recent Developments
    Table 101. Eli Lilly Company Details
    Table 102. Eli Lilly Business Overview
    Table 103. Eli Lilly Non-oncology Biopharmaceuticals Product
    Table 104. Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 105. Eli Lilly Recent Developments
    Table 106. Bristol-Myers Squibb Company Details
    Table 107. Bristol-Myers Squibb Business Overview
    Table 108. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product
    Table 109. Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 110. Bristol-Myers Squibb Recent Developments
    Table 111. GlaxoSmithKline Company Details
    Table 112. GlaxoSmithKline Business Overview
    Table 113. GlaxoSmithKline Non-oncology Biopharmaceuticals Product
    Table 114. GlaxoSmithKline Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 115. GlaxoSmithKline Recent Developments
    Table 116. UCB Pharma Company Details
    Table 117. UCB Pharma Business Overview
    Table 118. UCB Pharma Non-oncology Biopharmaceuticals Product
    Table 119. UCB Pharma Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 120. UCB Pharma Recent Developments
    Table 121. Amgen Company Details
    Table 122. Amgen Business Overview
    Table 123. Amgen Non-oncology Biopharmaceuticals Product
    Table 124. Amgen Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 125. Amgen Recent Developments
    Table 126. AbbVie Company Details
    Table 127. AbbVie Business Overview
    Table 128. AbbVie Non-oncology Biopharmaceuticals Product
    Table 129. AbbVie Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 130. AbbVie Recent Developments
    Table 131. Takeda Company Details
    Table 132. Takeda Business Overview
    Table 133. Takeda Non-oncology Biopharmaceuticals Product
    Table 134. Takeda Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 135. Takeda Recent Developments
    Table 136. AstraZeneca Company Details
    Table 137. AstraZeneca Business Overview
    Table 138. AstraZeneca Non-oncology Biopharmaceuticals Product
    Table 139. AstraZeneca Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 140. AstraZeneca Recent Developments
    Table 141. Mylan Company Details
    Table 142. Mylan Business Overview
    Table 143. Mylan Non-oncology Biopharmaceuticals Product
    Table 144. Mylan Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 145. Mylan Recent Developments
    Table 146. LEO Pharma Company Details
    Table 147. LEO Pharma Business Overview
    Table 148. LEO Pharma Non-oncology Biopharmaceuticals Product
    Table 149. LEO Pharma Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 150. LEO Pharma Recent Developments
    Table 151. Boehringer Ingelheim Company Details
    Table 152. Boehringer Ingelheim Business Overview
    Table 153. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product
    Table 154. Boehringer Ingelheim Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 155. Boehringer Ingelheim Recent Developments
    Table 156. Alexion Pharmaceuticals Company Details
    Table 157. Alexion Pharmaceuticals Business Overview
    Table 158. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product
    Table 159. Alexion Pharmaceuticals Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 160. Alexion Pharmaceuticals Recent Developments
    Table 161. Elusys Therapeutics Company Details
    Table 162. Elusys Therapeutics Business Overview
    Table 163. Elusys Therapeutics Non-oncology Biopharmaceuticals Product
    Table 164. Elusys Therapeutics Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 165. Elusys Therapeutics Recent Developments
    Table 166. Swedish Orphan Biovitrum Company Details
    Table 167. Swedish Orphan Biovitrum Business Overview
    Table 168. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product
    Table 169. Swedish Orphan Biovitrum Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 170. Swedish Orphan Biovitrum Recent Developments
    Table 171. Biogen Company Details
    Table 172. Biogen Business Overview
    Table 173. Biogen Non-oncology Biopharmaceuticals Product
    Table 174. Biogen Revenue in Non-oncology Biopharmaceuticals Business (2017-2022) & (US$ Million)
    Table 175. Biogen Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-oncology Biopharmaceuticals Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Biosimilars Features
    Figure 4. Global Non-oncology Biopharmaceuticals Market Share by Application: 2021 VS 2028
    Figure 5. Immunology Case Studies
    Figure 6. Endocrinology Case Studies
    Figure 7. Others Case Studies
    Figure 8. Non-oncology Biopharmaceuticals Report Years Considered
    Figure 9. Global Non-oncology Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Non-oncology Biopharmaceuticals Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Non-oncology Biopharmaceuticals Market Share by Region: 2021 VS 2028
    Figure 12. Global Non-oncology Biopharmaceuticals Market Share by Players in 2021
    Figure 13. Global Top Non-oncology Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Non-oncology Biopharmaceuticals Revenue in 2021
    Figure 15. North America Non-oncology Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 17. North America Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 18. North America Non-oncology Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 19. United States Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Non-oncology Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Non-oncology Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 25. Germany Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Non-oncology Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Non-oncology Biopharmaceuticals Market Size Share by Region (2017-2028)
    Figure 35. China Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Non-oncology Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Non-oncology Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 45. Mexico Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Non-oncology Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Share by Country (2017-2028)
    Figure 51. Turkey Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Non-oncology Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Roche Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 55. Sanofi Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 56. Johnson & Johnson Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 58. Novo Nordisk Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 61. Teva Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 65. UCB Pharma Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 66. Amgen Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 67. AbbVie Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 68. Takeda Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 69. AstraZeneca Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 70. Mylan Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 71. LEO Pharma Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 72. Boehringer Ingelheim Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 73. Alexion Pharmaceuticals Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 74. Elusys Therapeutics Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 75. Swedish Orphan Biovitrum Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 76. Biogen Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed